Data as of Oct 28, 2026.
ARKG vs XT: Holdings Overlap & Returns
Over the year to Oct 28, 2026, ARKG returned +80.0% to XT's +22.1%; 4% of their weight is in the same names.
askIQ about this page
askIQ about ARKG and XT
Net assets on Oct 27, 2026: $2.2bn for ARK Genomic Revolution ETF and $4.1bn for iShares Future Exponential Technologies ETF.
4% of ARKG's weight is in S&P 500 companies and 96% is outside the index. Holdings as of Oct 27, 2026.
66% of XT's weight is in S&P 500 companies and 35% is outside the index. Holdings as of Oct 27, 2026.
Pair scorecard
XT costs 0.29 points a year less; their one-year returns differ by 57.9 points; XT is 1.9 times larger.
Points (pts) are percentage points.
| Measure | ARKG | XT |
|---|---|---|
| Return | ||
| Total return, 1 year | +80.0% | +22.1% |
| Drawdown | ||
| Below its all-time high | 50.9%, high on Jan 20, 2021 | |
| Against its benchmark | ||
| What it tracks | Genomics and gene editing | Broad innovation and megatrends |
| Its benchmark, total return, 1 year | +13.4% | |
| Against its benchmark, 1 year | ahead by 8.7 pts | |
| Cost and size | ||
| Expense ratio | 0.75% | 0.46% |
| Net assets, as of Oct 27, 2026 | $2.2bn | $4.1bn |
| Active share vs the S&P 500 | 98% | 69% |
| Holdings | ||
| Holdings in common | 4% | |
Holdings in common uses holdings dated Oct 27, 2026. Method
Risk and return
Apr 2, 2015 to Oct 23, 2026 · 603 weekly returnsXT returned more: +292.0% to +130.2%. XT swung less: 19.0% to 40.4%. XT fell less at its worst: −34.3% to −82.9%.
Full scorecard
9 measures, with how each is measured Open ↓
| Measure | ARKG | XT | Edge | How it is measured |
|---|---|---|---|---|
| Return | ||||
| Total return | +130.2% | +292.0% | XT | Price change plus distributions, reinvested. |
| Annualized | +7.5% | +12.5% | XT | Total return as a yearly rate. |
| Price return | +115.4% | +225.6% | XT | Price change alone, distributions left out. |
| Risk | ||||
| Volatility | 40.4% | 19.0% | XT | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 26.6% | 13.2% | XT | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −82.9% | −34.3% | XT | Deepest fall from a high to the low after it. |
| Risk-adjusted | ||||
| Sharpe | 0.32 | 0.60 | XT | Return above Treasury bills per unit of volatility. |
| Sortino | 0.49 | 0.87 | XT | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.09 | 0.36 | XT | Annualized return divided by the max drawdown. |
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 603 weekly returns. Cash rate: the 13-week Treasury bill.
What they share
By the books each fund has filed, ARKG and XT hold 4% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.
half
4% in common
Only in one fund ↓
Window by window
| Total return | vs its benchmark | |||
|---|---|---|---|---|
| Window | ARKG | XT | ARKG | XT |
| 3 months | +46.2% | +10.2% | not measured | +5.8 pts vs ACWI |
| 6 months | +92.1% | +14.0% | not measured | +6.6 pts vs ACWI |
| 1 year | +80.0% | +22.1% | not measured | +8.7 pts vs ACWI |
| 3 years | +146.5% | +93.2% | not measured | +4.3 pts vs ACWI |
| Since launchNot the same days: ARKG Oct 2014 · XT Mar 2015 | +191.5% | +297.8% | not measured | +71.7 pts vs ACWI |
Side by side
As of Oct 28, 2026. Source: ETFIQ.
4% of the two portfolios are the same securities at the same weight.
ARKG and XT are built for the same job. How do they differ in cost, holdings and results?
- Theme. ARKG covers Genomics and gene editing and XT covers Broad innovation and megatrends.
- Concentration. The top ten holdings are 58.3% of ARKG and 36.6% of XT, a gap of 21.7 points.
- What each follows. ARKG follows Genomics and gene editing and XT follows Broad innovation and megatrends.
Data as of Oct 28, 2026.
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
ARKG
By weight, 4% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +80.0% with distributions reinvested. It sits 50.9% below its all-time high of Jan 20, 2021.
XT
By weight, 66% of XT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 69%. The top ten holdings are 37% of the fund across 197 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +22.1% with distributions reinvested against +13.4% for its benchmark, the MSCI All Country World Index, so a holder was ahead by 8.7 pts.
Questions people ask
- Do ARKG and XT hold the same stocks?
- By their latest filings, 4% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, ARKG against XT, data as of Oct 28, 2026. https://etfiq.com/compare/themes/arkg-vs-xt
ETFIQ. (Oct 28, 2026). ARKG against XT. Retrieved from https://etfiq.com/compare/themes/arkg-vs-xt
[ARKG against XT (ETFIQ, Oct 28, 2026)](https://etfiq.com/compare/themes/arkg-vs-xt)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.